SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001720
Filing Date
2020-02-28
Accepted
2020-02-28 08:10:17
Documents
106
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sbbp-20191231x10k.htm 10-K 4176326
2 EX-4.1 sbbp-20191231ex4119e9447.htm EX-4.1 68176
3 EX-10.8 sbbp-20191231ex10841ffff.htm EX-10.8 168944
4 EX-10.16 sbbp-20191231ex101628adb.htm EX-10.16 48752
5 EX-10.25 sbbp-20191231ex10255df5a.htm EX-10.25 86184
6 EX-10.26 sbbp-20191231ex10264568a.htm EX-10.26 16652
7 EX-21.1 sbbp-20191231ex211488331.htm EX-21.1 3280
8 EX-23.1 sbbp-20191231ex231062bbe.htm EX-23.1 4569
9 EX-31.1 sbbp-20191231ex31160edd2.htm EX-31.1 16210
10 EX-32.1 sbbp-20191231ex3219a542d.htm EX-32.1 9626
11 GRAPHIC sbbp20191231ex10841ffff001.jpg GRAPHIC 10802
12 GRAPHIC sbbp20191231x10k001.jpg GRAPHIC 324012
13 GRAPHIC sbbp20191231x10k002.jpg GRAPHIC 181231
14 GRAPHIC sbbp20191231x10k003.jpg GRAPHIC 28443
15 GRAPHIC sbbp20191231x10k004.jpg GRAPHIC 89512
  Complete submission text file 0001558370-20-001720.txt   13631160

Data Files

Seq Description Document Type Size
16 EX-101.INS sbbp-20191231.xml EX-101.INS 2605373
17 EX-101.SCH sbbp-20191231.xsd EX-101.SCH 69093
18 EX-101.CAL sbbp-20191231_cal.xml EX-101.CAL 83122
19 EX-101.DEF sbbp-20191231_def.xml EX-101.DEF 255616
20 EX-101.LAB sbbp-20191231_lab.xml EX-101.LAB 633440
21 EX-101.PRE sbbp-20191231_pre.xml EX-101.PRE 502858
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 10-K | Act: 34 | File No.: 001-37569 | Film No.: 20665712
SIC: 2834 Pharmaceutical Preparations